Invesaro

Stocks Comparison

Smith & Nephew vs Zimmer Biomet: revenue, profit, margins and growth compared

Smith & Nephew brought in $6.2B of revenue in fiscal 2025, Zimmer Biomet $8.2B in fiscal 2025. Revenue changed by +6.1% at Smith & Nephew and +7.2% at Zimmer Biomet on the year before, so Zimmer Biomet grew faster. Smith & Nephew kept 10.1% of its revenue as net profit, Zimmer Biomet 8.6%.

Open the SNN pageOpen the ZBH page

Side by side, latest fiscal year

SNNZBH
Fiscal year endedFY2025 (December 31, 2025)FY2025 (December 31, 2025)
Revenue$6.2B$8.2B
Revenue growth+6.1%+7.2%
Net income$625M$705.1M
Net margin10.1%8.6%
Free cash flown/a$1.5B
Free cash flow marginn/a17.9%
Earnings per share (diluted)$0.72$3.55
Cash$557M$591.9M
Debt$3.1B$7.5B
Price to earningsn/a25.8
Market value$11.5B$17.5B
Dividend yieldn/a1.05%
Rank by revenue in sector#56 of 742 · Health care#53 of 742 · Health care

Over the years

Revenue
SNN FY2018: $4.9BSNN FY2019: $5.1BSNN FY2020: $4.6BSNN FY2021: $5.2BSNN FY2022: $5.2BSNN FY2023: $5.5BSNN FY2024: $5.8BSNN FY2025: $6.2BZBH FY2018: $7.9BZBH FY2019: $8BZBH FY2020: $6.1BZBH FY2021: $6.8BZBH FY2022: $6.9BZBH FY2023: $7.4BZBH FY2024: $7.7BZBH FY2025: $8.2BFY18FY19FY20FY21FY22FY23FY24FY25
SNN $6.2BZBH $8.2B
Net income
SNN FY2018: $663MSNN FY2019: $600MSNN FY2020: $448MSNN FY2021: $524MSNN FY2022: $223MSNN FY2023: $263MSNN FY2024: $412MSNN FY2025: $625MZBH FY2018: -$379.2MZBH FY2019: $1.1BZBH FY2020: -$138.9MZBH FY2021: $401.6MZBH FY2022: $231.4MZBH FY2023: $1BZBH FY2024: $903.8MZBH FY2025: $705.1MFY18FY19FY20FY21FY22FY23FY24FY25
SNN $625MZBH $705.1M
Net margin
SNN FY2018: 13.5%SNN FY2019: 11.7%SNN FY2020: 9.8%SNN FY2021: 10.1%SNN FY2022: 4.3%SNN FY2023: 4.7%SNN FY2024: 7.1%SNN FY2025: 10.1%ZBH FY2018: -4.8%ZBH FY2019: 14.2%ZBH FY2020: -2.3%ZBH FY2021: 5.9%ZBH FY2022: 3.3%ZBH FY2023: 13.8%ZBH FY2024: 11.8%ZBH FY2025: 8.6%FY18FY19FY20FY21FY22FY23FY24FY25
SNN 10.1%ZBH 8.6%
Revenue growth
SNN FY2019: +4.8%SNN FY2020: -11.2%SNN FY2021: +14.3%SNN FY2022: +0.1%SNN FY2023: +6.4%SNN FY2024: +4.7%SNN FY2025: +6.1%ZBH FY2019: +0.6%ZBH FY2020: -23.2%ZBH FY2021: +11.4%ZBH FY2022: +1.6%ZBH FY2023: +6.5%ZBH FY2024: +3.8%ZBH FY2025: +7.2%FY19FY20FY21FY22FY23FY24FY25
SNN +6.1%ZBH +7.2%
Free cash flow
ZBH FY2018: $1.6BZBH FY2019: $1.4BZBH FY2020: $1.1BZBH FY2021: $1.4BZBH FY2022: $1.2BZBH FY2023: $1.3BZBH FY2024: $1.3BZBH FY2025: $1.5BFY18FY19FY20FY21FY22FY23FY24FY25
SNNZBH $1.5B

Fiscal years as each company reports them; the two may end in different months.

Questions about Smith & Nephew and Zimmer Biomet

Which is bigger by revenue, Smith & Nephew or Zimmer Biomet?

Zimmer Biomet is bigger by revenue: $8.2B in fiscal 2025, against $6.2B for Smith & Nephew in fiscal 2025.

Which keeps more of its revenue as profit, Smith & Nephew or Zimmer Biomet?

Smith & Nephew had a net margin of 10.1% in fiscal 2025; Zimmer Biomet had 8.6% in fiscal 2025.

Which grew revenue faster, Smith & Nephew or Zimmer Biomet?

In their latest fiscal years revenue changed by +6.1% at Smith & Nephew and +7.2% at Zimmer Biomet.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

ISRG vs SNN
EW vs SNN
SNN vs STE
ISRG vs ZBH
EW vs ZBH
STE vs ZBH

Compare more companies